Previous Article | Next Article 
Infection and Immunity, March 1999, p. 1424-1431, Vol. 67, No. 3
0019-9567/99/$04.00+0
Copyright © 1999, American Society for Microbiology. All rights reserved.
Characterization of Human Bactericidal Antibodies
to Bordetella pertussis
Alison A.
Weiss,1,*
Paula S.
Mobberley,1
Rachel C.
Fernandez,1,
and
ChrisAnna M.
Mink2
Department of Molecular Genetics, Biochemistry and
Microbiology, University of Cincinnati, Cincinnati, Ohio
45267-0524,1 and Saint Louis
University, Center for Vaccine Development, St. Louis, Missouri
631102
Received 4 November 1998/Accepted 14 December 1998
The Bordetella pertussis BrkA protein protects against
the bactericidal activity of complement and antibody; however, some individuals mount an immune response that overcomes this bacterial defense. To further characterize this process, the bactericidal activities of sera from 13 adults with different modes of exposure to
B. pertussis (infected as adults, occupational exposure,
immunized with an acellular vaccine, or no identified exposure) against a wild-type strain and a BrkA complement-sensitive mutant were evaluated. All of the sera killed the BrkA mutant, suggesting past
exposure to B. pertussis or cross-reactive organisms.
Several samples had no or minimal activity against the wild type. All of the sera collected from the infected and occupationally exposed individuals but not all of the sera from vaccinated individuals had
bactericidal activity against the wild-type strain, suggesting that
some types of exposure can induce an immune response that can overcome
the BrkA resistance mechanism. Adsorbing serum with the wild-type
strain removed the bactericidal antibodies; however, adsorbing the
serum with a lipopolysaccharide (LPS) mutant or an avirulent
(bvg mutant) strain did not always result in loss of
bactericidal activity, suggesting that antibodies to either LPS or
bvg-regulated proteins could be bactericidal. All the
samples, including those that lacked bactericidal activity, contained
antibodies that recognized the LPS of B. pertussis.
Bactericidal activity correlated best with the presence of the
immunoglobulin G3 (IgG3) antibodies to LPS, the IgG subtype that is
most effective at fixing complement.
*
Corresponding author. Mailing address: Department of
Molecular Genetics, Biochemistry and Microbiology, University of
Cincinnati, 531 Bethesda Ave., ML 524, Cincinnati, OH 45267-0524. Phone: (513) 558-2120. Fax: (513) 558-8474. E-mail:
Alison.Weiss{at}uc.edu.

Present address: Department of Microbiology and Immunology,
University of British Columbia, Vancouver, British Columbia, Canada
V6T
1Z3.
Infection and Immunity, March 1999, p. 1424-1431, Vol. 67, No. 3
0019-9567/99/$04.00+0
Copyright © 1999, American Society for Microbiology. All rights reserved.
This article has been cited by other articles:
-
Stefanelli, P., Sanguinetti, M., Fazio, C., Posteraro, B., Fadda, G., Mastrantonio, P.
(2006). Differential In Vitro Expression of the brkA Gene in Bordetella pertussis and Bordetella parapertussis Clinical Isolates.. J. Clin. Microbiol.
44: 3397-3400
[Abstract]
[Full Text]
-
Niedziela, T., Letowska, I., Lukasiewicz, J., Kaszowska, M., Czarnecka, A., Kenne, L., Lugowski, C.
(2005). Epitope of the Vaccine-Type Bordetella pertussis Strain 186 Lipooligosaccharide and Antiendotoxin Activity of Antibodies Directed against the Terminal Pentasaccharide-Tetanus Toxoid Conjugate. Infect. Immun.
73: 7381-7389
[Abstract]
[Full Text]
-
Weiss, A. A., Patton, A. K., Millen, S. H., Chang, S.-J., Ward, J. I., Bernstein, D. I.
(2004). Acellular Pertussis Vaccines and Complement Killing of Bordetella pertussis. Infect. Immun.
72: 7346-7351
[Abstract]
[Full Text]
-
Rambow-Larsen, A. A., Weiss, A. A.
(2004). Temporal Expression of Pertussis Toxin and Ptl Secretion Proteins by Bordetella pertussis. J. Bacteriol.
186: 43-50
[Abstract]
[Full Text]
-
Burns, V. C., Pishko, E. J., Preston, A., Maskell, D. J., Harvill, E. T.
(2003). Role of Bordetella O Antigen in Respiratory Tract Infection. Infect. Immun.
71: 86-94
[Abstract]
[Full Text]
-
Stenson, T. H., Weiss, A. A.
(2002). DsbA and DsbC Are Required for Secretion of Pertussis Toxin by Bordetella pertussis. Infect. Immun.
70: 2297-2303
[Abstract]
[Full Text]
-
Barnes, M. G., Weiss, A. A.
(2002). Growth Phase Influences Complement Resistance of Bordetella pertussis. Infect. Immun.
70: 403-406
[Abstract]
[Full Text]
-
Barnes, M. G., Weiss, A. A.
(2001). BrkA Protein of Bordetella pertussis Inhibits the Classical Pathway of Complement after C1 Deposition. Infect. Immun.
69: 3067-3072
[Abstract]
[Full Text]
-
Weingart, C. L., Mobberley-Schuman, P. S., Hewlett, E. L., Gray, M. C., Weiss, A. A.
(2000). Neutralizing Antibodies to Adenylate Cyclase Toxin Promote Phagocytosis of Bordetella pertussis by Human Neutrophils. Infect. Immun.
68: 7152-7155
[Abstract]
[Full Text]
-
Weingart, C. L., Keitel, W. A., Edwards, K. M., Weiss, A. A.
(2000). Characterization of Bactericidal Immune Responses following Vaccination with Acellular Pertussis Vaccines in Adults. Infect. Immun.
68: 7175-7179
[Abstract]
[Full Text]
-
Weingart, C. L., Weiss, A. A.
(2000). Bordetella pertussis Virulence Factors Affect Phagocytosis by Human Neutrophils. Infect. Immun.
68: 1735-1739
[Abstract]
[Full Text]
-
Lenz, D. H., Weingart, C. L., Weiss, A. A.
(2000). Phagocytosed Bordetella pertussis Fails To Survive in Human Neutrophils. Infect. Immun.
68: 956-959
[Abstract]
[Full Text]
-
Weingart, C. L., Broitman-Maduro, G., Dean, G., Newman, S., Peppler, M., Weiss, A. A.
(1999). Fluorescent Labels Influence Phagocytosis of Bordetella pertussis by Human Neutrophils. Infect. Immun.
67: 4264-4267
[Abstract]
[Full Text]